These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 37243310

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Transthyretin amyloid cardiomyopathy disease burden quantified using 99mTc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
    Watanabe S, Nakajima K, Toshima F, Wakabayashi H, Yoshida S, Yoneyama H, Komatsu J, Konishi T, Kinuya S.
    J Nucl Cardiol; 2023 Dec; 30(6):2721-2735. PubMed ID: 37605060
    [Abstract] [Full Text] [Related]

  • 27. Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.
    Bourque JM, Schepart A, Bhambri R, Castaño A, O'Brien A, Chen Y, Prasad S, Roy A, Grodin JL.
    Am J Cardiol; 2022 Mar 15; 167():98-103. PubMed ID: 35022130
    [Abstract] [Full Text] [Related]

  • 28. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
    Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M, Johnson LL, Flaherty KR, Saith SE, Griffin JM, Perotte A, Maurer MS.
    JACC Cardiovasc Imaging; 2021 Jun 15; 14(6):1221-1231. PubMed ID: 33221204
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases.
    Chan N, Einstein AJ, Griffin JM, Rosenblum H, Teruya S, Cuomo M, De Los Santos J, DeLuca A, Johnson LL, Kinkhabwala MP, Leb JS, Mintz A, Fine D, Helmke S, Muralidhar V, Pandey S, Sabogal N, Saith SE, Winburn M, Smiley D, Miller EJ, Ruberg FL, Maurer MS.
    J Nucl Cardiol; 2023 Dec 15; 30(6):2531-2539. PubMed ID: 37311914
    [Abstract] [Full Text] [Related]

  • 33. Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis.
    Takahashi K, Sasaki D, Yamashita M, Sakaue T, Enomoto D, Morioka H, Uemura S, Okura T, Ikeda S, Kono T, Hiratsuka Y, Saijo A, Yamamura N, Kitazawa S, Yamashita T, Ueda M.
    J Nucl Cardiol; 2022 Dec 15; 29(6):3126-3136. PubMed ID: 34964085
    [Abstract] [Full Text] [Related]

  • 34. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.
    Martyn T, Saef J, Hussain M, Ives L, Kiang A, Estep JD, Collier P, Starling RC, Cremer PC, Tang WHW, Hanna M, Jaber WA.
    J Card Fail; 2022 Oct 15; 28(10):1509-1518. PubMed ID: 35843490
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Diagnostic value of heart-to-mediastinum ratio in 99mTc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis.
    Ikoma T, Ohtani H, Ohno K, Iguchi K, Suwa K, Sawada M, Tanahashi Y, Sakamoto A, Saotome M, Ichikawa S, Goshima S, Maekawa Y.
    J Nucl Cardiol; 2023 Aug 15; 30(4):1374-1381. PubMed ID: 36547805
    [Abstract] [Full Text] [Related]

  • 38. Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters.
    Watanabe S, Nakajima K, Wakabayashi H, Yoneyama H, Yoshida S, Komatsu J, Konishi T, Inaki A, Kinuya S.
    J Nucl Cardiol; 2022 Dec 15; 29(6):3102-3110. PubMed ID: 34907500
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association Between Atrial Uptake on Cardiac Scintigraphy With Technetium-99m-Pyrophosphate Labeled Bone-Seeking Tracers and Atrial Fibrillation.
    Hussain M, Krywanczyk A, Donnellan E, Martyn T, Hassan OA, Alkharabsheh S, Watson C, Tang WH, Kwon D, Cremer P, Cheng F, Kanj M, Griffin B, Tan C, Rodriguez ER, Hanna M, Jaber W, Collier P.
    Circ Cardiovasc Imaging; 2022 May 15; 15(5):e013829. PubMed ID: 35580157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.